Coverage of our work on antimicrobial resistance, plus a press kit and a direct media contact for journalists, event organisers, and partners.
Founder Samwel Elegwa joined KUTV Kenya's Art & Culture Monday to explain antimicrobial resistance and why faster, genome-driven diagnostics matter for patients, clinicians, and public health systems.
Watch the interview
Samwel Elegwa and William Otieno represented BactoAI at the BIK Ventures Hub startup pitch event at Kenyatta University. The event was covered in print and in BIK's recap video, which features several of the innovations showcased, including BactoAI.
Watch BIK's coverageThe BactoAI wordmark with the bacterial emblem, for use in articles and event material. Please keep clear space around it and don't recolour it.
Download logo (PNG)A concise overview of the platform, our validation approach, and current pilot opportunities. Available on request while we finalise the public version.
Request one-pagerOur founder and team are available for interviews and background briefings on antimicrobial resistance, genomic diagnostics, and health innovation in East Africa.
Request an interviewBactoAI is a Kenyan health-technology company building an AMR intelligence platform that predicts antimicrobial resistance directly from bacterial genomes, helping clinicians and laboratories reach the right treatment decision faster. The platform is built and owned by BactoAI as a company, combining biotechnology, software engineering, machine learning, operations, and partnerships expertise.
For interviews, event invitations, data requests, or fact-checking, email us directly — we usually reply within two working days.
